DMD and neoplasm: Although, as expected, the presence of some types of somatic mutations and SCNAs was associated with lower levels of DMD expression, in about 88% of tumor samples and 77% of cell lines, DMD downregulation could not be linked to mutations in the coding regions of the DMD gene.